![Por qué la tercera dosis de la vacuna contra la COVID-19 es fundamental contra Ómicron | National Geographic Por qué la tercera dosis de la vacuna contra la COVID-19 es fundamental contra Ómicron | National Geographic](https://static.nationalgeographic.es/files/styles/image_3200/public/ngscience-2112-omicron-protection_primary_ai2html_fallback.jpg?w=1900&h=3188)
Por qué la tercera dosis de la vacuna contra la COVID-19 es fundamental contra Ómicron | National Geographic
![Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/21aefd8d-1880-42db-8338-92a386a5842f/gr1.jpg)
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
![Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33169-0/MediaObjects/41467_2022_33169_Fig1_HTML.png)
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications
![Boosters vital to mitigate impact of Omicron, but may lose some effectiveness | Imperial News | Imperial College London Boosters vital to mitigate impact of Omicron, but may lose some effectiveness | Imperial News | Imperial College London](https://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1639520932245_mainnews2012_x1.webp)
Boosters vital to mitigate impact of Omicron, but may lose some effectiveness | Imperial News | Imperial College London
![Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/91d19b8e-2f0b-4e13-8d9b-69e012d37e25/gr1.jpg)
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
![Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7118a4-F-large.gif?_=74292)
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
![Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England | Nature Communications Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-35168-7/MediaObjects/41467_2022_35168_Fig1_HTML.png)
Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England | Nature Communications
![Sputnik V on X: "Canadian real-world study of mRNA vaccines efficiency vs # Omicron shows negative efficacy of 2 mRNA doses and quickly waning efficiency of homologous #mRNA booster: “A third dose provides Sputnik V on X: "Canadian real-world study of mRNA vaccines efficiency vs # Omicron shows negative efficacy of 2 mRNA doses and quickly waning efficiency of homologous #mRNA booster: “A third dose provides](https://pbs.twimg.com/media/FIPiC5yXoAYJFaO.jpg)
Sputnik V on X: "Canadian real-world study of mRNA vaccines efficiency vs # Omicron shows negative efficacy of 2 mRNA doses and quickly waning efficiency of homologous #mRNA booster: “A third dose provides
![Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675.jpg?_=42783)